bibliographic resource 6575 [br/6575]
https://w3id.org/oc/corpus/br/6575
- is a
-
- title
-
- PEAK: A Randomized, Multicenter Phase II Study of Panitumumab Plus Modified Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) or Bevacizumab Plus mFOLFOX6 in Patients With Previously Untreated, Unresectable, Wild-Type KRAS Exon 2 Metastatic Colorectal Cancer
- publication date
-
- contributor
-
- format
-
- identifier
-
- part of
-